We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Therapeutic potential of interleukin-15 in cancer (Review).
- Authors
Isvoranu, Gheorghita; Surcel, Mihaela; Munteanu, Adriana Narcisa; Bratu, Ovidiu Gabriel; Ionita-Radu, Florentina; Neagu, Monica Teodora; Chiritoiu-Butnaru, Marioara
- Abstract
The immune system is dysfunctional in cancer, and therapeutic approaches designated to restore immunity and increase long-term overall survival are desirable. The role of immunotherapy is to trigger the immune system to recognize and destroy tumor cells. Interleukin-15 (IL-15) is a member of the common gamma-chain (γc) cytokines that promote the differentiation and expansion of T cells, B cells and natural killer (NK) cells, leading to enhanced antitumor responses. This suggests that IL-15 is a promising candidate for anticancer therapy. Renewed interest in cancer immunotherapy has led to an increased number of preclinical studies and clinical trials that have investigated the reliability and potency of IL-15-based agents, not only as single therapy, but also in combination with others. This review provides a description of these studies which show the advantages and disadvantages of IL-15 as an immunotherapeutic agent. We present here the role of IL-15 and pharmacologically improved IL-15 superagonists as a single treatment or in combination with other therapeutic agents.
- Subjects
INTERLEUKIN-15; KILLER cells; T cell differentiation; OVERALL survival; B cells
- Publication
Experimental & Therapeutic Medicine, 2021, Vol 22, Issue 1, pN.PAG
- ISSN
1792-0981
- Publication type
Article